Stereotaxis (STXS) Operating Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Stereotaxis (STXS) Operating Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | -201.00 |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 722.00 |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 162.00 |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 586.00 |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 736.00 |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 887.00 |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -1,075.00 |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 963.00 |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 244.00 |
| 10 | Stereotaxis | 129.55 Mn | 114.93 Mn | 3.79 Mn | -926.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -926.00 |
| Dec 31, 2025 | -433.00 |
| Sep 30, 2025 | -2,187.00 |
| Jun 30, 2025 | 3,898.00 |
| Mar 31, 2025 | -2,124.00 |
| Dec 31, 2024 | -7,966.00 |
| Sep 30, 2024 | -1,826.00 |
| Jun 30, 2024 | -9,628.00 |
| Mar 31, 2024 | -5,126.00 |
| Dec 31, 2023 | -9,895.00 |
| Sep 30, 2023 | -5,435.00 |
| Jun 30, 2023 | -3,120.00 |
| Mar 31, 2023 | -5,016.00 |
| Dec 31, 2022 | -4,382.00 |
| Sep 30, 2022 | -6,548.00 |
| Jun 30, 2022 | -6,271.00 |
| Mar 31, 2022 | -2,759.00 |
| Dec 31, 2021 | -3,257.00 |
| Sep 30, 2021 | -4,923.00 |
| Jun 30, 2021 | -2,917.00 |